Laser photocoagulation is a procedure that uses a focused beam of light to seal leaking blood vessels, destroy abnormal tissue, or create protective scars inside the eye. It’s one of the most established treatments in ophthalmology, used primarily for conditions that threaten the retina, the light-sensitive tissue at the back of your eye. The procedure has been shown to reduce the risk of severe vision loss from proliferative diabetic retinopathy by 50 to 60 percent compared to no treatment.
How the Laser Works on Retinal Tissue
The laser delivers a precise beam of light that passes through the front of the eye and is absorbed by pigmented tissue in the retina. That absorption converts light energy into heat, and the temperature rise is what does the therapeutic work. When retinal tissue heats up by about 22 degrees above its baseline, irreversible changes begin. At roughly 41 degrees above baseline, clearly visible treatment spots form. This controlled thermal damage causes proteins in the tissue to denature, essentially cooking a tiny area of cells into a permanent scar.
These scars serve different purposes depending on the condition being treated. In diabetic retinopathy, destroying oxygen-hungry photoreceptor cells reduces the retina’s overall demand for oxygen. The scar tissue that replaces those cells is thinner, allowing more oxygen from the blood supply behind the retina to diffuse forward and relieve the oxygen starvation that drives the disease. Scar tissue formed during healing may also release compounds that actively suppress the growth of abnormal new blood vessels.
For retinal tears, the concept is different. The laser creates a ring of scar tissue around the tear that essentially welds the retina to the tissue underneath it, forming a barrier that prevents fluid from seeping through and peeling the retina away in a full detachment.
Conditions Treated With Photocoagulation
The most common reason for laser photocoagulation is diabetic eye disease. It treats both proliferative diabetic retinopathy, where abnormal new blood vessels grow on the retina’s surface, and diabetic macular edema, where fluid leaks into the central retina and blurs vision. Other conditions include retinal vein occlusion, choroidal neovascularization (abnormal vessel growth beneath the retina), retinal tears, and retinopathy of prematurity in newborns.
For diabetic macular edema specifically, laser treatment was the standard of care for decades after a landmark trial showed it could stabilize visual acuity. That role has shifted with the introduction of anti-VEGF injections, drugs that block the growth signal driving leaky blood vessels. Laser is no longer used alone as a first-line treatment when swelling affects the center of your vision. However, it remains an effective option for macular edema that doesn’t involve the center of the macula, and it’s used as an add-on therapy for chronic cases that don’t fully respond to injections.
Types of Laser Treatment
There are three main approaches, and the one your doctor recommends depends on where the problem is and how widespread it is.
Focal photocoagulation targets individual leaking spots, typically tiny bulges in blood vessel walls called microaneurysms. The laser is aimed directly at each leaking point to seal it shut. This is the technique used for localized macular edema.
Grid photocoagulation applies a pattern of evenly spaced laser spots across a broader area of the retina where diffuse leakage is occurring. Rather than targeting specific vessels, it treats a zone of tissue to reduce overall fluid buildup.
Panretinal photocoagulation (PRP) is the most extensive approach. It places hundreds to thousands of laser burns across the peripheral retina, deliberately destroying large areas of oxygen-starved tissue to halt the growth of dangerous new blood vessels. PRP is the primary laser treatment for proliferative diabetic retinopathy and severe non-proliferative disease.
Conventional vs. Pattern Scanning Lasers
Traditional PRP uses continuous laser pulses of about 100 milliseconds each. Newer pattern scanning systems deliver much shorter pulses, typically 10 to 30 milliseconds, and can place multiple spots in a rapid grid pattern with a single press. The shorter pulse time means less total heat energy enters the eye, which causes less thermal damage to surrounding tissue and significantly less discomfort during the procedure. Both methods use similar power levels (250 to 700 milliwatts) and spot sizes (around 400 micrometers).
Laser Types and Wavelengths
Different laser wavelengths penetrate and are absorbed by retinal tissue differently. Argon green lasers, operating at 514 nanometers, have historically been the workhorse of retinal photocoagulation. They’re well absorbed by both the pigment layer of the retina and by blood, making them versatile for most conditions. Krypton red lasers at 647 nanometers penetrate deeper and are less absorbed by blood, which made them useful for treating structures beneath the retina. Modern practice has largely consolidated around solid-state lasers that can produce similar wavelengths with greater reliability and less maintenance.
What to Expect During the Procedure
For adults, the procedure is typically done in an office setting. Your eye is numbed with anesthetic drops, and your pupil is dilated. A special contact lens is placed on your eye to focus the laser beam and keep your eye steady. You’ll sit at a machine similar to the one used for routine eye exams, and the doctor delivers the laser pulses while looking through a microscope.
Each laser pulse feels like a brief pinch or sting. Focal treatments, which involve fewer spots, may take only 10 to 15 minutes. PRP sessions take longer because hundreds of spots are needed, and the treatment is often split across two or more visits to reduce side effects. With pattern scanning lasers, sessions can be completed more quickly and with less discomfort than conventional methods.
After treatment, your vision will be blurry for several hours from the dilating drops, and you may notice dark spots where the laser was applied. Antibiotic and anti-inflammatory eye drops are typically prescribed for a few days afterward. Most people can return to normal activities the next day, though driving immediately after is not possible due to the dilation.
Side Effects and Risks
The side effects of laser photocoagulation depend heavily on the type and extent of treatment. Focal laser for macular edema carries relatively modest risks, though laser scars can slowly enlarge over years, a phenomenon called “atrophic creep,” which can affect nearby vision if scars were placed close to the center of the macula.
PRP carries more significant trade-offs because it intentionally destroys peripheral retinal tissue. The most common effects include reduced peripheral vision (your side vision narrows), decreased night vision, and temporary worsening of macular edema. Less common complications include fluid collection beneath the retina and, rarely, retinal detachment. These complications are more likely when higher power settings are used, pulses are longer, or too many spots are applied in a single session. Spreading PRP across multiple visits and using pattern scanning lasers both help reduce these risks.
The visual field loss from PRP is permanent, since the destroyed retinal cells don’t regenerate. For many patients this is a worthwhile trade-off to prevent the catastrophic vision loss that untreated proliferative retinopathy can cause, but it’s one reason anti-VEGF injections have become an alternative. Studies comparing the two approaches have found that anti-VEGF therapy is associated with lower rates of new or worsening macular edema compared to PRP alone.
How Effective Is the Treatment?
The evidence behind laser photocoagulation for diabetic retinopathy is some of the strongest in ophthalmology. The Diabetic Retinopathy Study, which began reporting results in the 1970s, found that PRP reduced the two-year risk of severe vision loss by about 60 percent. Among eyes with the highest-risk features, untreated eyes had a 26 percent chance of severe vision loss at two years, compared to 11 percent in treated eyes. That protective effect remained remarkably consistent over extended follow-up, ranging between 56 and 59 percent risk reduction.
For macular edema, the Early Treatment Diabetic Retinopathy Study established that focal and grid laser could stabilize visual acuity and reduce the risk of moderate vision loss. While anti-VEGF injections now produce better visual gains for center-involving edema, laser remains effective for non-center-involving cases and as a supplemental treatment to reduce the number of injections a patient needs over time.
Follow-Up After Treatment
Laser photocoagulation is not always a one-time fix. After PRP, your doctor will monitor for regression of the abnormal blood vessels and may add more laser spots if needed. After focal treatment, the effects of individual burns can be assessed within about a month, but recurrence is common. In studies of one type of retinal condition treated with focal laser, roughly 70 percent of cases showed initial improvement within two months, but over half experienced recurrence within one to four years, requiring additional treatment.
Follow-up schedules vary by condition, but expect visits every few months in the first year after treatment. Your doctor will use imaging to track whether leaking vessels have sealed, whether new abnormal vessels have appeared, and whether any retreatment is needed. Long-term monitoring continues for years, since the underlying conditions that led to treatment, particularly diabetes, remain ongoing risks for further retinal damage.